Trial intelligence / Profile preview

Particulate vs Nonparticulate Corticosteroids for Musculoskeletal Conditions

NCT04278833Phase 4Terminated

Sponsor
Stanford University
Start
Sep 2020
Primary completion
May 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of triamcinolone, betamethasone and dexamethasone in osteoarthritis (OA), tendinopathy and shoulder impingement syndrome (SIS) (2 arms), sponsored by Stanford University. Primary endpoints: Mean Change in Average Pain From Baseline at 6 months and Number of Participants With ≥50% Decrease in Pain From Baseline at 6 months. Started Sep 2020; status: terminated.

02

Drugs

triamcinolonebetamethasonedexamethasone
03

Conditions

osteoarthritis (OA)tendinopathyshoulder impingement syndrome (SIS)

Beyond the preview

Go deeper on NCT04278833.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04278833.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call